
1. malar j. 2016 nov 26;15(1):572.

insight k13-propeller gene polymorphism ex vivo dha-response profiles
from cameroonian isolates.

menard s(1), tchoufack jn(2), maffo cn(2), nsango se(2)(3), iriart x(1)(4), abate
l(5), tsapi mt(5), awono-ambéné ph(2), abega mekongo fa(6), morlais i(5), berry
a(7)(8).

author information: 
(1)centre de physiopathologie de toulouse purpan, inserm u1043, cnrs umr5282,
université de toulouse, toulouse, france.
(2)laboratoire d'entomologie médicale, organisation de coordination pour la lutte
contre les endémies en afrique centrale, yaoundé, cameroon.
(3)faculté de médecine et des sciences pharmaceutiques, université de douala,
douala, cameroon.
(4)service de parasitologie-mycologie, chu toulouse, toulouse, france.
(5)umr mivegec, ird 224-cnrs5290-um, institut de recherche pour le développement,
montpellier, france.
(6)dispensaire de nkol-eton, bp894, yaounde, cameroon.
(7)centre de physiopathologie de toulouse purpan, inserm u1043, cnrs umr5282,
université de toulouse, toulouse, france. berry.a@chu-toulouse.fr.
(8)service de parasitologie-mycologie, chu toulouse, toulouse, france.
berry.a@chu-toulouse.fr.

background: spread plasmodium falciparum resistance artemisinin
derivatives southeast asia major source concern emergence of
resistance africa would dramatic consequences, increasing malaria
mortality morbidity. therefore urgent implement regular monitoring
in sentinel sites sub-saharan africa using robust easy-to-implement tools.
the prevalence k13-propeller mutations phenotypic profiles poorly 
known sub-saharan africa. here, k13-propeller polymorphism compared to
both ex vivo susceptibility dha early parasitological clinical
responses artemisinin combination therapy (act).
methods: plasmodium falciparum isolates collected 2015 yaoundé
(cameroon) patients treated dihydroartemisinin-piperaquine combination.
samples analysed susceptibility artemisinin using the
k13-propeller sequencing, ex vivo ring-stage survival assay, vivo
parasite positive rate clinical statute day 2.
results: none collected isolates revealed presence resistance
mutations k13-propeller sequence. median ring-stage survival rate 
all 64 interpretable isolates 6-hour pulse 700 nm
dihydroartemisinin low, 0.49% (iqr: 0-1.3). total parasite clearance was
observed 87.5% patients remaining parasitaemic isolates (12.5%)
showed high reduction parasite load, ranging 97.5 99.9%. clinical
symptoms disappeared 92.8% cases.
conclusion: study demonstrated absence k13-resistant genotypes p. 
falciparum isolates cameroon. synonymous mutations found a
low prevalence (4.3%). good association k13 genotypes ex vivo
ring-stage survival assay parasitological clinical data obtained.
these results give baseline long-term monitoring artemisinin
derivative efficacy africa.

doi: 10.1186/s12936-016-1622-x 
pmcid: pmc5124315
pmid: 27887614  [indexed medline]

